Access cutting-edge rsv infection treatment through this clinical trial at a research site in Seattle. Study-provided care at no cost to qualified participants.
Access rsv infection specialists in Seattle at no cost
This study follows strict safety protocols and ethical guidelines
All study-related rsv infection treatment provided free
This phase II trial tests how well remdesivir works for treatment of respiratory syncytial virus (RSV) infection of the upper respiratory tract in patients receiving cellular or bispecific antibody therapy. Cellular or bispecific antibody therapies cause suppression of the immune system, making infections more frequent and reducing the body's ability to fight the infections. RSV infections are one of the most common respiratory infections in immunocompromised individuals and can cause significan
Sponsor: Fred Hutchinson Cancer Center
Check if you qualify for this rsv infection clinical trial in Seattle, WA
If you're searching for rsv infection treatment options in Seattle, WA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Seattle research site is actively enrolling participants for this clinical trial. You'll receive care from experienced rsv infection specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.